Red Blood Cells (RBCs)-derived particles are an emerging group of novel drug delivery
systems. The natural attributes of RBCs make them potential candidates for use as a drug …

Erythrocytes have gained popularity as a natural option for in vivo drug delivery due to their
advantages, which include lengthy circulation times, biocompatibility, and biodegradability …

Protein glycosylation controls cell–cell and cell–extracellular matrix (ECM) communication in
immune, vascular, and inflammatory processes, underlining the critical role of this process in …

Scientific organizations worldwide are striving to create drug delivery systems that provide a
high local concentration of a drug in pathological tissue without side effects on healthy …

Red blood cell-derived extracellular vesicles (RBC EVs) are small, spherical fragments
released from red blood cells. These vesicles, similar to EVs derived from other cell types …

Hypoxic tumor microenvironment (TME) hampers the application of oxygen (O2)‐dependent
photodynamic therapy (PDT) in solid tumors. To address this problem, a biomimetic …

Red blood cell (RBC)-based systems are under extensive development as platforms for the
delivery of various biomedical agents. While the importance of the membrane biochemical …

Cytoreductive surgery remains as the gold standard to treat ovarian cancer, but with limited
efficacy since not all tumors can be intraoperatively visualized for resection. We have …

In this study, a series of poly (amino acid) s materials with amphiphilic properties were
synthesized by ring-opening polymerization. In specific solvents, macromolecules can self …

Introduction We have previously described the preclinical developments in enzyme-loaded
red blood cells to be used in the treatment of several rare diseases, as well as in chronic …